Semipermeability imparted by surface-active phospholipid in peritoneal dialysis

Peritoneal Dialysis International

Volumn 22, Issue 3, 2002, Pages 380-385

  Chen, Yi ^a   Burke, John R ^a   Hills, Brian A ^a  

^a MATER CHILDREN S HOSPITAL   (Australia)

Author keywords

Exogenous surfactant; Osmotic pressure; Replenishment in peritoneal dialysis; Semi permeable membrane; Surface active phospholipid; Ultrafiltration

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; GLUCOSE; LIPID; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; SODIUM CHLORIDE; SOLVENT; SURFACTANT; WATER;

ADSORPTION; ARTICLE; CASE REPORT; CLINICAL STUDY; CONTROLLED STUDY; DIALYSATE; DRUG FORMULATION; DRUG SAFETY; HUMAN; LIPOPHILICITY; MEMBRANE PERMEABILITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; OSMOTIC PRESSURE; PERITONEAL DIALYSIS; PHYSICAL CHEMISTRY; POROSITY; POWDER; PRIORITY JOURNAL; SOLUBILITY; STATISTICAL SIGNIFICANCE; ULTRAFILTRATION;

EID: 0036586855     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200313     Document Type: Article

References (31)

1. Grahame GR, Torchia MG, Dankewich KA, Ferguson IA. Surface-active material in peritoneal effluent on CAPD patients. Perit Dial Bull 1985; 5:109-11.
2. Hills BA, Butler BD, Barrow RE. Boundary lubrication imparted by pleural surfactants and their identification. J Appl Physiol 1982; 53:463-9.
3. Hills BA. Graphite-like lubrication of mesothelium by oligolamellar pleural surfactant. J Appl Physiol 1992; 73:1034-9.
4. Chen Y, Hills BA. Surgical adhesions: evidence for adsorption of surfactant to peritoneal mesothelium. Aust N Z J Surg 2000; 70:443-7.
5. Hills BA, Burke JR, Thomas K. Surfactant barrier lining peritoneal mesothelium: lubricant and release agent. Perit Dial Int 1998; 18:157-65.
6. Dobbie JW. Surfactant protein A and lamellar bodies: a homologous secretory function of peritoneum, synovium, and lung. Perit Dial Int 1996; 16:574-81.
7. Stratton CJ. Morphology of surfactant producing cells and of the alveolar lining. In: Robertson B, van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant. Amsterdam: Elsevier; 1984:68-118.
8. Di Paolo N, Buoncristiani U, Gaggiotto E, Capotondo L, De Mia M. Improvement of impaired ultrafiltration after addition of phosphatidy1choline in patients on CAPD. Perit Dial Bull 1986; 6:44-5.
9. Hills BA. Role of surfactant in peritoneal dialysis. Perit Dial Int 2000; 20:503-15.
10. Querques M, Procaccini DA, Pappani A, Strippoli P, Passione A. Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients. ASAIO Rans 1990; 36:M581-3.
11. Lang J, Harwood J, Coles GA, Williams JD. Changes in dialysate phospholipid content during CAPD (Abstract). Perit Dial Int 1992; 12(Suppl 2):S513.
12. Dombros N, Balaskas E, Savidis N, Tourkantonis A, Sombolos K. Phosphatidylcholine increases ultrafiltration in continuous ambulatory peritoneal dialysis patients. In: Avram MM, Giordans S, eds. Ambulatory Peritoneal Dialysis. New York: Plenum; 1990:39-40.
13. Krack G, Viglino G, Cavalli PL, Gandolfo C, Magliano G, Cantaluppi A, et al. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12:359-64.
14. Breborowicz A, Sombolos K, Rodela H, Olgilvie R, Bargman J, Oreopoulos D. Mechanism of phosphatidylcholine action during peritoneal dialysis. Perit Dial Bull 1987; 7:6-9.
15. Flessner MF, Dedrik ML, Schultz JD. A distribution model of peritoneal plasma transport: analysis of experimental data in the rat. Am J Physiol 1985; 248:F413-24.
16. Wang T, Qureshi AR, Heimbürger O, Waniewski J, Chen C, Bergström J, et al. Dioctyl sodium succinate increases wet ultrafiltration in peritoneal dialysis. Nephrol Dial Transplant 1997; 12:1218-22.
17. Flessner MF, Lofthouse J, Zakaria ER. Improving contact area between the peritoneum and intraperitoneal therapeutic solutions. J Am Soc Nephrol 2001; 12:807-13.
18. Fane AG, Fell CJO, Kim KJ. The effect of surfactant pretreatment on the ultrafiltration of proteins. Desalination 1985; 53:37.
19. Sourirajan S. Reverse Osmosis. New York: Academic Press; 1970:97.
20. Sourirajan S, Matsuura T. Science of reverse osmosis - an essential tool for the chemical engineer. J Chromatogr 1982; 166:359.
21. Hills BA. Possible role of adsorbed surfactant in controlling membrane permeability. Med Hypotheses 1989; 28:85-92.
22. Folch J, Lees M, Sloane-Stanley GH. A simple method for, the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226:497-509.
23. Gluck L, Kulovich MV, Borer RC Jr, Brenner PH, Anderson GG, Spellacy WN. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 1971; 109:440-6.
24. Glasstone S. Textbook of Physical Chemistry, 2nd ed. London: Macmillan; 1953:1196-217.
25. Bangham AD. Liposomes in nuce. Biol Cell 1983; 47:1-10.
26. Wickes AD, Howell SB. Pharmacokinetics of hexamethylmelamine administrated via the IP route in an oil emulsion vehicle. Cancer Treat Rep 1985; 69:657-62.
27. Tanford C. The Hydrophobic Effect: Formation of Micelles and Biological Membranes, 2nd ed. New York: Wiley; 1980:206.
28. Bangham AD. Artificial lung expanding compound (ALEC). In: Lasic DD, Papahadjopoulous D, eds. Medical Application of Liposomes. Amsterdam: Elsevier; 1998:455-72.
29. Morley CJ, Bangham AD, Johnson P, Thorburn GD, Jenkin G. Physical and physiological properties of dry lung surfactant. Nature 1978; 271:162-3.
30. Morley CJ, Bangham AD, Miller N, Davis JA. Dry artificial lung surfactant and its effect on very premature babies. Lancet 1981; 1(8211):64-8.
31. Bhandarkar DS, Nathanson LK, Hills BA. Spray of phospholipid powder reduces peritoneal adhesions in rabbits. Aust N Z J Surg 1999; 69:388-90.